ID   PA2GX_HUMAN             Reviewed;         165 AA.
AC   O15496; Q14DU3; Q6NT23;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   16-JUN-2009, sequence version 3.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=Group 10 secretory phospholipase A2;
DE            EC=3.1.1.4;
DE   AltName: Full=Group X secretory phospholipase A2;
DE            Short=GX sPLA2;
DE            Short=sPLA2-X;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase 10;
DE   Flags: Precursor;
GN   Name=PLA2G10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   TISSUE=Lung;
RX   PubMed=9188469; DOI=10.1074/jbc.272.25.15745;
RA   Cupillard L., Koumanov K., Mattei M.-G., Lazdunski M., Lambeau G.;
RT   "Cloning, chromosomal mapping, and expression of a novel human
RT   secretory phospholipase A2.";
RL   J. Biol. Chem. 272:15745-15752(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.97 ANGSTROMS) OF 43-165, DISULFIDE BONDS,
RP   ACTIVE SITE, COFACTOR, AND CALCIUM-BINDING SITES.
RX   PubMed=12161451; DOI=10.1074/jbc.M202531200;
RA   Pan Y.H., Yu B.Z., Singer A.G., Ghomashchi F., Lambeau G., Gelb M.H.,
RA   Jain M.K., Bahnson B.J.;
RT   "Crystal structure of human group X secreted phospholipase A2.
RT   Electrostatically neutral interfacial surface targets zwitterionic
RT   membranes.";
RL   J. Biol. Chem. 277:29086-29093(2002).
CC   -!- FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2-
CC       acyl groups in 3-sn-phosphoglycerides. Has a powerful potency for
CC       releasing arachidonic acid from cell membrane phospholipids.
CC       Prefers phosphatidylethanolamine and phosphatidylcholine liposomes
CC       to those of phosphatidylserine.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10035, ECO:0000255|PROSITE-ProRule:PRU10036}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:12161451};
CC       Note=Binds 1 Ca(2+) ion per subunit.
CC       {ECO:0000269|PubMed:12161451};
CC   -!- INTERACTION:
CC       Q0VD86:INCA1; NbExp=4; IntAct=EBI-726466, EBI-6509505;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Found in spleen, thymus, peripheral blood
CC       leukocytes, pancreas, lung, and colon.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U95301; AAB64410.1; -; mRNA.
DR   EMBL; CR456885; CAG33166.1; -; mRNA.
DR   EMBL; AC009167; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471112; EAW85104.1; -; Genomic_DNA.
DR   EMBL; BC069539; AAH69539.1; -; mRNA.
DR   EMBL; BC106731; AAI06732.1; -; mRNA.
DR   EMBL; BC106732; AAI06733.1; -; mRNA.
DR   EMBL; BC111804; AAI11805.1; -; mRNA.
DR   CCDS; CCDS10555.1; -.
DR   RefSeq; NP_003552.1; NM_003561.2.
DR   UniGene; Hs.567366; -.
DR   PDB; 1LE6; X-ray; 1.97 A; A/B/C=43-165.
DR   PDB; 1LE7; X-ray; 2.09 A; A/B=43-165.
DR   PDB; 4UY1; X-ray; 2.20 A; A/B=43-165.
DR   PDB; 5G3M; X-ray; 1.85 A; A/B=43-165.
DR   PDBsum; 1LE6; -.
DR   PDBsum; 1LE7; -.
DR   PDBsum; 4UY1; -.
DR   PDBsum; 5G3M; -.
DR   ProteinModelPortal; O15496; -.
DR   SMR; O15496; -.
DR   BioGrid; 113987; 52.
DR   IntAct; O15496; 48.
DR   MINT; MINT-1411106; -.
DR   STRING; 9606.ENSP00000393847; -.
DR   BindingDB; O15496; -.
DR   ChEMBL; CHEMBL4342; -.
DR   GuidetoPHARMACOLOGY; 1422; -.
DR   SwissLipids; SLP:000001084; -.
DR   iPTMnet; O15496; -.
DR   PaxDb; O15496; -.
DR   PeptideAtlas; O15496; -.
DR   PRIDE; O15496; -.
DR   Ensembl; ENST00000438167; ENSP00000393847; ENSG00000069764.
DR   Ensembl; ENST00000621727; ENSP00000479397; ENSG00000276870.
DR   GeneID; 8399; -.
DR   KEGG; hsa:8399; -.
DR   UCSC; uc002dcq.4; human.
DR   CTD; 8399; -.
DR   DisGeNET; 8399; -.
DR   GeneCards; PLA2G10; -.
DR   H-InvDB; HIX0026959; -.
DR   HGNC; HGNC:9029; PLA2G10.
DR   HPA; HPA041893; -.
DR   MIM; 603603; gene.
DR   neXtProt; NX_O15496; -.
DR   OpenTargets; ENSG00000069764; -.
DR   PharmGKB; PA33360; -.
DR   eggNOG; KOG4087; Eukaryota.
DR   eggNOG; ENOG411283D; LUCA.
DR   GeneTree; ENSGT00760000119160; -.
DR   HOGENOM; HOG000231749; -.
DR   HOVERGEN; HBG008137; -.
DR   InParanoid; O15496; -.
DR   KO; K01047; -.
DR   OMA; QELLCKC; -.
DR   OrthoDB; EOG091G0UZ3; -.
DR   PhylomeDB; O15496; -.
DR   TreeFam; TF319283; -.
DR   BRENDA; 3.1.1.4; 2681.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-HSA-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-HSA-1482922; Acyl chain remodelling of PI.
DR   Reactome; R-HSA-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   EvolutionaryTrace; O15496; -.
DR   GeneWiki; PLA2G10; -.
DR   GenomeRNAi; 8399; -.
DR   PRO; PR:O15496; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000069764; -.
DR   CleanEx; HS_PLA2G10; -.
DR   ExpressionAtlas; O15496; baseline and differential.
DR   Genevisible; O15496; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; TAS:Reactome.
DR   GO; GO:0004620; F:phospholipase activity; ISS:BHF-UCL.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; NAS:BHF-UCL.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; IDA:MGI.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISS:BHF-UCL.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0051977; P:lysophospholipid transport; IDA:MGI.
DR   GO; GO:0090370; P:negative regulation of cholesterol efflux; ISS:BHF-UCL.
DR   GO; GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0090238; P:positive regulation of arachidonic acid secretion; ISS:BHF-UCL.
DR   GO; GO:0032270; P:positive regulation of cellular protein metabolic process; IMP:BHF-UCL.
DR   GO; GO:0010884; P:positive regulation of lipid storage; IMP:BHF-UCL.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IC:BHF-UCL.
DR   GO; GO:0032308; P:positive regulation of prostaglandin secretion; IMP:BHF-UCL.
DR   GO; GO:0043030; P:regulation of macrophage activation; IMP:BHF-UCL.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR033112; PLipase_A2_Asp_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cleavage on pair of basic residues;
KW   Complete proteome; Disulfide bond; Glycoprotein; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     31       {ECO:0000255}.
FT   PROPEP       32     42       {ECO:0000255}.
FT                                /FTId=PRO_0000022764.
FT   CHAIN        43    165       Group 10 secretory phospholipase A2.
FT                                /FTId=PRO_0000022765.
FT   ACT_SITE     88     88       {ECO:0000269|PubMed:12161451}.
FT   ACT_SITE    133    133       {ECO:0000269|PubMed:12161451}.
FT   METAL        68     68       Calcium; via carbonyl oxygen.
FT   METAL        70     70       Calcium; via carbonyl oxygen.
FT   METAL        72     72       Calcium; via carbonyl oxygen.
FT   METAL        89     89       Calcium.
FT   CARBOHYD    113    113       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     53    111       {ECO:0000269|PubMed:12161451}.
FT   DISULFID     67    157       {ECO:0000269|PubMed:12161451}.
FT   DISULFID     69     85       {ECO:0000269|PubMed:12161451}.
FT   DISULFID     84    139       {ECO:0000269|PubMed:12161451}.
FT   DISULFID     90    164       {ECO:0000269|PubMed:12161451}.
FT   DISULFID     91    132       {ECO:0000269|PubMed:12161451}.
FT   DISULFID    100    125       {ECO:0000269|PubMed:12161451}.
FT   DISULFID    118    130       {ECO:0000269|PubMed:12161451}.
FT   HELIX        44     54       {ECO:0000244|PDB:5G3M}.
FT   STRAND       55     57       {ECO:0000244|PDB:5G3M}.
FT   HELIX        59     62       {ECO:0000244|PDB:5G3M}.
FT   STRAND       63     65       {ECO:0000244|PDB:1LE6}.
FT   TURN         66     68       {ECO:0000244|PDB:5G3M}.
FT   STRAND       69     72       {ECO:0000244|PDB:5G3M}.
FT   HELIX        80     97       {ECO:0000244|PDB:5G3M}.
FT   TURN        102    104       {ECO:0000244|PDB:5G3M}.
FT   STRAND      109    111       {ECO:0000244|PDB:5G3M}.
FT   STRAND      116    118       {ECO:0000244|PDB:5G3M}.
FT   HELIX       124    141       {ECO:0000244|PDB:5G3M}.
FT   HELIX       147    149       {ECO:0000244|PDB:5G3M}.
FT   HELIX       154    156       {ECO:0000244|PDB:5G3M}.
SQ   SEQUENCE   165 AA;  18153 MW;  AD197A164319F102 CRC64;
     MGPLPVCLPI MLLLLLPSLL LLLLLPGPGS GEASRILRVH RRGILELAGT VGCVGPRTPI
     AYMKYGCFCG LGGHGQPRDA IDWCCHGHDC CYTRAEEAGC SPKTERYSWQ CVNQSVLCGP
     AENKCQELLC KCDQEIANCL AQTEYNLKYL FYPQFLCEPD SPKCD
//
